Graduating from @eupati here in Madrid tomorrow and being acknowledged as a new Board of Governor The Patient-Centered Outcomes Research Institute Annual Meeting today.

This #BreastCancerAwarenessMonth , let's not forget patients like Julia Maués, the reason we do what we do. This community has scientific experts, but the most fundamental expertise comes from understanding what life is like with this disease. Thank you, Julia, for all you do.

If you aren’t involving patient #advocacy from the earliest stages of designing your #oncology #clinicaltrials , you are doing #drugdevelopment wrong. It’s true.

I was honored to guest lecture yesterday for the 9th year at University of Pittsburgh 1st year Genetic Counseling grad students. I’m always happy to share our journey living with #Duchenne Thanks for inviting me back ⁦Pitt Genetic Counseling Program⁩ #DMD #raredisease #geneticcounseling

Thanks so much Julia Maués for this important message for the #cancer research community. #patientexpertise #patientengagement #patientsmatter

Julia Maués BioAscend TRUTH Julia Maués pink 💖!
Quote of the onc season…✨

Always amazed when oncs assert chemo is not such a difficult thing. They clearly have not had close family really bringing home the experience for them…🙏🏻

An annual ritual in our community - acknowledging the death of too many from breast cancer. We honor them and never forget. OurMBCLife #bcsm #stage4needsmore

As true in #Cancer as it is in #RareDisease and so many disease spaces and types. The patient perspective is not just vital, it's essential. 💪

We sincerely apologize to everyone who was blasted with emails about hotel registration for #SABCS22 . Especially if you already registered. We're like you.

Featured speaker, Dr Clayton Yates Clayton Yates PhD of Johns Hopkins Kimmel Cancer Center and TUSKEGEE UNIVERSITY will give us a summary of his years of work in prostate cancer disparities, including his recent Genomic Sequencing study of Nigerian men from the CaPTC

Estudo realizado no Inca buscou avaliar os resultados de sobrevida em pts com CA mama HIV+ vs pts HIV- tratadas na instituição entre 2000 e 2014. Os resultados publicados na The Breast - tinyurl.com/2x38fkhj #MAMA #HIV #INCA #ONCONEWS

PATIENTS are the experts in LIVING with cancer.

Thanks, BioAscend, for this video!

Another ER+ press release. These drugs are coming - I remain confident we will have new endocrine backbones for our patients.

And please consider a clinical trial...TODAY!

#bcsm #CERAN #endocrine Sarah Cannon Docs
ir.olema.com/news-releases/…

Excited to review the data at the upcoming meeting! Congrats to all involved. Camizestrant Significantly Improved Progression-free Survival Vs. FASLODEX® (fulvestrant) in SERENA-2 Phase II Trial in Advanced ER-positive Breast Cancer | Business Wire businesswire.com/news/home/2022…